Healthcare Innovation

Leveraged finance titans turned a personal fight into a philanthropic powerhouse, raising a record $4.3M to fund the science that’s turning the tide on melanoma.

The Jim Henson Company's 'Monster Dance' uses cutting-edge tech and creative choreography to teach kids emotional literacy. It's more than a show; it's a new paradigm.

Wellness brands often struggle to turn concepts into viable products. A Utah-based CDMO's new PhD-led center is bridging the gap from science to scale.

As AblePay marks a decade of growth, we examine how its 'win-win' model for patients and providers is reshaping healthcare affordability and revenue cycles.

As summer heat strains Tulsa foundations, a local business initiative highlights the growing risk of hidden slab leaks, a costly problem rooted in local geology.

A $4M grant for a Parkinson's drug isn't just charity; it's a strategic bet on a new era of medicine, where philanthropy acts as the catalyst for the next big cure.

A record $1.3B IPO, a minister's endorsement, and a new $75M fund. Apotex's TSX debut isn't just a corporate win; it's a national strategy in motion.

A key deal locking in generic drug prices is extended, promising billions in savings for healthcare and providing crucial stability for a fragile industry.

A key clinical trial completion in Japan signals a major shift in prostate cancer care, heralding the arrival of advanced PSMA-targeted theranostics.

After nearly half a century, Yakult Singapore's new peach flavor is more than a product update. It's a calculated move in a high-stakes 'cultured war'.

Athletes are ditching complex supplement stacks for all-in-one EAA formulas. We explore the science and the industry shift fueling this minimalist movement.

As AI reshapes childhood with risks of addiction and anxiety, advocates argue that the oldest classroom—nature—is the most vital tool for building resilience.

An award for a digital hall pass reveals a deeper shift in education, where AI promises unprecedented safety but raises new questions about student autonomy.

Polish biotech firm Urteste S.A. enrolls its first patient in a pivotal trial for a non-invasive pancreatic cancer test, a milestone in the global race for early diagnosis.

The Japanese Soy Milk Exchange launches to introduce a new premium category. Can heritage, technology, and high protein win over U.S. consumers?

Organon's FDA nod for TOFIDENCE in critical care isn't just a clinical win. It's a calculated move to capture market share and challenge high-cost biologics.

A landmark deal sees Novartis invest up to $1.4B in Orionis Biosciences' AI platform, aiming to turn the chance discovery of 'molecular glue' drugs into a science.

With $101M from top VCs, Ethyreal Bio emerges from stealth to target the root cause of both Graves' Disease and Thyroid Eye Disease with a single antibody.

A new 225-residence community breaks ground in Issaquah, aiming to address the Eastside's senior housing shortage with an integrated healthcare model.

Biotech firm Sensorion drops one gene therapy to fast-track another, aiming to cure GJB2-related hearing loss, the leading cause of genetic deafness.